Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in JSPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,766
-$181,993 QoQ
Shares Held
11,149
-89.4% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Derivatives in JSPR

reported options exposure · as of Dec 31, 2025
CallValue
$63,318
CallShares
34,600
PutValue
$18,849
PutShares
10,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. JSPR ranks #351 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JSPR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,766 11,149
2025-12-31 $18,849 10,300
2025-12-31 $63,318 34,600
2025-12-31 $191,759 104,787
2025-09-30 $61,642 25,900
2025-09-30 $62,118 26,100
2025-09-30 $84,708 35,592
2025-06-30 $156,510 28,200
2025-06-30 $198,690 35,800
2025-06-30 $337,917 60,886
2025-03-31 $69,191 16,091
2025-03-31 $101,910 23,700
2024-12-31 $947,134 44,300
2024-12-31 $463,946 21,700
2024-12-31 $487,763 22,814
2024-09-30 $1,356,201 72,100
2024-09-30 $1,640,232 87,200
2024-09-30 $385,981 20,520
2024-06-30 $742,290 32,700
2024-06-30 $2,574,180 113,400
2024-03-31 $408,104 13,900
2024-03-31 $2,941,872 100,200
2024-03-31 $237,346 8,084